MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
The current MannKind(MNKD) stock price is $3.96, with a market capitalization of 1.38B. The stock trades at a price-to-earnings (P/E) ratio of -52.56.
On 2026-08-06, MannKind(MNKD) stock moved within a range of $3.85 to $4.14. With shares now at $3.96, the stock is trading +2.9% above its intraday low and -4.3% below the session's peak.
Trading activity shows a volume of 6.83M, compared to an average daily volume of 5.17M.
Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.
Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.
MNKD News
Reports Q2 revenue $109.37M, consensus $108.8M. “This was a transformative period for MannKind (MNKD), during which we delivered all three major catalysts we se...
...
In late July 2026, MannKind reported positive topline Phase 1b results for its inhaled nintedanib in idiopathic pulmonary fibrosis and secured FDA approval for...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.